- 全部删除
- 您的购物车当前为空
RIPK1-IN-17 是一种 RIPK1 和 RIPK3 双重抑制剂,通过抑制RIPK1、RIPK3和MLKL的磷酸化特异性地抑制坏死,在tnf诱导的炎症模型中保护小鼠免于低温和死亡。
为众多的药物研发团队赋能,
让新药发现更简单!
RIPK1-IN-17 是一种 RIPK1 和 RIPK3 双重抑制剂,通过抑制RIPK1、RIPK3和MLKL的磷酸化特异性地抑制坏死,在tnf诱导的炎症模型中保护小鼠免于低温和死亡。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 445 | In stock | |
5 mg | ¥ 1,070 | In stock | |
10 mg | ¥ 1,590 | In stock | |
25 mg | ¥ 2,680 | In stock | |
50 mg | ¥ 3,930 | In stock | |
100 mg | ¥ 5,730 | In stock |
产品描述 | RIPK1-IN-17 is a dual inhibitor of RIPK1 and RIPK3 that specifically inhibits necrosis by inhibiting phosphorylation of RIPK1, RIPK3 and MLKL, protecting mice from hypothermia and death in a tnf-induced inflammation model. |
分子量 | 529.51 |
分子式 | C26H19F4N3O3S |
CAS No. | 3033385-59-7 |
Smiles | FC1=C(NC(CC2=CC=CC(OC(F)(F)F)=C2)=O)C=C(C3=CC=C(N=C(NC(C4CC4)=O)S5)C5=C3)C=C1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40.00 mg/mL (75.54 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容